The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A - II | Alive

Total Raised


Last Raised

$4M | 4 yrs ago

About ApoGen Biotechnologies

ApoGen Biotechnologies is a biotechnology company focused on the development of therapeutics targeting drivers of cancer genomic mutation. ApoGen is building upon technologies developed at the University of Minnesota to develop drugs that block a key pathway that causes drug resistance. ApoGen's drug discovery and development efforts are directed toward selective and potent small molecule inhibitors of the APOBEC family of enzymes, which are DNA cytosine deaminases and an endogenous source of DNA mutation in cancer.

ApoGen Biotechnologies Headquarter Location

2815 Eastlake Avenue East Suite 300

Seattle, Washington, 98102,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ApoGen Biotechnologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ApoGen Biotechnologies is included in 3 Expert Collections, including Cancer.



4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data


Biopharma Tech

838 items

Latest ApoGen Biotechnologies News

ApoGen expands series A to $11M

Sep 3, 2018

ApoGen expands series A to $11M 11:13 AM PDF Drug-resistant cancer company ApoGen Biotechnologies Inc. raised an additional $4 million on Aug. 23 from M Ventures and existing investors in its series A round, bringing the round's total to $11 million. M Ventures is the venture arm... Read the full 166 word article User Sign in

ApoGen Biotechnologies Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ApoGen Biotechnologies Rank

  • When was ApoGen Biotechnologies founded?

    ApoGen Biotechnologies was founded in 2014.

  • Where is ApoGen Biotechnologies's headquarters?

    ApoGen Biotechnologies's headquarters is located at 2815 Eastlake Avenue East, Seattle.

  • What is ApoGen Biotechnologies's latest funding round?

    ApoGen Biotechnologies's latest funding round is Series A - II.

  • How much did ApoGen Biotechnologies raise?

    ApoGen Biotechnologies raised a total of $11M.

  • Who are the investors of ApoGen Biotechnologies?

    Investors of ApoGen Biotechnologies include WRF Capital, M Ventures, WuXi AppTec, AbbVie Biotech Ventures, IBM Watson Group and 8 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.